OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

NCT07140783 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Vision Loss Night
Vision Disorders

Interventions

DRUG: 0.75% Phentolamine Ophthalmic Solution
DRUG: Placebo

Sponsor

Ocuphire Pharma, Inc.